The global neonatal thermoregulation market is estimated to be valued at USD 661.8 million in 2023 and is projected to reach USD 1,151.6 million by 2033, exhibiting a compound annual growth rate (CAGR) of 5.7% during this period.
Growing awareness regarding neonatal care has been fuelling the sales of neonatal thermoregulation equipment suppliers around the world for the past decade, while the rise in demand from the hospitals sector is further catering to it. Despite getting temporarily declined during the outbreak of the deadly COVID-19 pandemic in 2020, the industry players are gaining momentum again with the steady recovery in key end-use sectors.
The latest revised report on the neonatal thermoregulation market by Future Market Insights (FMI) provides a detailed analysis of the global industry, growth & restraining factors, and demand-supply patterns during the forecast period of 2023 to 2033.
Future Market Insights anticipates that suppliers and manufacturers will target the leading regions such as North America, Europe, and Asia Pacific, while China, India, the United States, Japan, and a few others countries will remain highly lucrative throughout the forecast period.
Growth Drivers
- The increasing awareness regarding neonatal care has significantly fueled the demand for neonatal thermoregulation equipment, which is essential for maintaining the appropriate body temperature of newborns.
- The rise in hospital admissions for neonates, especially preterm infants who are more susceptible to temperature fluctuations, has further contributed to market growth.
Key Trends
- There is a growing emphasis on the importance of proper thermoregulation in hospitals to ensure the health and well-being of newborns, leading to increased investments in advanced neonatal care technologies.
- Despite a temporary decline during the COVID-19 pandemic, the market is witnessing a recovery as healthcare facilities resume normal operations and focus on improving neonatal outcomes.
Competitive Landscape
With the competition getting stricter each passing year, key industry players are emphasizing on bringing in diverse range of neonatal thermoregulation devices and equipment.
- Inspiration Healthcare Group Plc. launched its new Tecotherm Neo., INSPIRE NCPAP™, and others during the last 5 years.
- Atom Medical Corporation launched its new Incu i, Transport Incubator, Infant Warmer, and others a couple of years back.
- GE Healthcare created a Giraffe Incubator Carestation in April 2022. The Giraffe Carestation is a cutting-edge neonatal facility aimed at encouraging natural and calm healing. It strengthens the family’s bond with the infant, permitting them to be present at each phase.
- Natus Medical Incorporated, an established supplier of medical device approaches for the assessment, treatment, and diagnosis of conditions impacting the brain, neural circuits, and eight sensory systems of the brain, disclosed in April 2022 that it had signed into a definitive contract to be obtained by a Natus Medical Incorporated subsidiary. ArchiMed is a healthcare-focused startup with a $1.2 billion valuation.
Get Complete Full Report
Key Companies Profiled
- GE Healthcare
- Natus Medical Incorporated
- Inspiration Healthcare Group Plc.
- Koninklijke Philips N.V.
- Dragerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare
- International Biomedical, Ltd.
- Atom Medical Corporation
- Fanem Ltda
- Novos Medical Systems
- Pluss Advanced Technologies Pvt. Ltd.
- Weyer GmbH
Key Segments Profiled in the Neonatal Thermoregulation Industry Survey
Product Type:
- Warmer
- Radiant Warmer
- Wall Mount Warmer
- Neonatal Incubators
- Intensive Care Incubator
- Hybrid Incubator
- Selective Close Care Incubators
- Transport Incubator
- Intensive Care Incubator
- Neonatal Cooling Systems
Modality:
- Open
- Close
End User:
- Hospitals
- Paediatric and Neonatal
- Intensive Care Units
- Others
Region:
- North America
- Latin America
- Europe
- Middle East and Africa
- East Asia
- South Asia
- Oceania
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
